|
1
|
Zhang M, Miao F, Huang R, Liu W, Zhao Y,
Jiao T, Lu Y, Wu F, Wang X, Wang H, et al: RHBDD1 promotes
colorectal cancer metastasis through the Wnt signaling pathway and
its downstream target ZEB1. J Exp Clin Cancer Res. 37:222018.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hawley SA, Pan DA, Mustard KJ, Ross L,
Bain J, Edelman AM, Frenguelli BG and Hardie DG:
Calmodulin-dependent protein kinase kinase-beta is an alternative
upstream kinase for AMP-activated protein kinase. Cell Metab.
2:9–19. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dorward HS, Du A, Bruhn MA, Wrin J, Pei
JV, Evdokiou A, Price TJ, Yool AJ and Hardingham JE:
Pharmacological blockade of aquaporin-1 water channel by AqB013
restricts migration and invasiveness of colon cancer cells and
prevents endothelial tube formation in vitro. J Exp Clin Cancer
Res. 35:362016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Slattery ML, Herrick JS, Mullany LE,
Samowitz WS, Sevens JR, Sakoda L and Wolff RK: The co-regulatory
networks of tumor suppressor genes, oncogenes, and miRNAs in
colorectal cancer. Genes Chromosomes Cancer. 56:769–787. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Eshghifar N, Farrokhi N, Naji T and Zali
M: Tumor suppressor genes in familial adenomatous polyposis.
Gastroenterol Hepatol Bed Bench. 10:3–13. 2017.PubMed/NCBI
|
|
7
|
Tiainen M, Vaahtomeri K, Ylikorkala A and
Mäkelä TP: Growth arrest by the LKB1 tumor suppressor: Induction of
p21WAF1/CIP1. Hum Mol Genet. 11:1497–1504. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ylikorkala A, Rossi DJ, Korsisaari N,
Luukko K, Alitalo K, Henkemeyer M and Mäkelä TP: Vascular
abnormalities and deregulation of VEGF in
Lkb1-deficient mice. Science. 293:1323–1326. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hardie DG and Alessi DR: LKB1 and AMPK and
the cancer-metabolism link-ten years after. BMC Biol. 11:362013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jeon SM and Hay N: The double-edged sword
of AMPK signaling in cancer and its therapeutic implications. Arch
Pharm Res. 38:346–357. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Larsen AK, de Gramont A, Poindessous V,
Bouygues A, Ayadi M and Mésange P: Functions and clinical
implications of autocrine VEGF signaling in colorectal cancer. Curr
Colorect Cancer Rep. 9:270–277. 2013. View Article : Google Scholar
|
|
12
|
Deguchi A, Miyoshi H, Kojima Y, Okawa K,
Aoki M and Taketo MM: LKB1 suppresses p21-activated kinase-1 (PAK1)
by phosphorylation of Thr109 in the p21-binding domain.
J Biol Chem. 285:18283–18290. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim SW: The role of MicroRNAs in
colorectal cancer. Korean J Gastroenterol. 69:206–211. 2017.(In
Korean). View Article : Google Scholar : PubMed/NCBI
|
|
14
|
You HX, Zhou YH, Tan SY and She TH:
Effects of silencing RIP1 with siRNA on the biological behavior of
the LoVo human colon cancer cell line. Oncol Lett. 7:2065–2072.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
He G, Zou L, Zhou L, Gao P, Qian X and Cui
J: Cysteine-rich intestinal protein 1 silencing inhibits migration
and invasion in human colorectal cancer. Cell Physiol Biochem.
44:897–906. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zakikhani M, Dowling RJ, Sonenberg N and
Pollak MN: The effects of adiponectin and metformin on prostate and
colon neoplasia involve activation of AMP-activated protein kinase.
Cancer Prev Res. 1:369–375. 2008. View Article : Google Scholar
|
|
17
|
Song X, Kim SY, Zhang L, Tang D, Bartlett
DL, Kwon YT and Lee YJ: Role of AMP-activated protein kinase in
cross-talk between apoptosis and autophagy in human colon cancer.
Cell Death Dis. 5:e15042014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lipovka Y and Konhilas JP: AMP-activated
protein kinase signalling in cancer and cardiac hypertrophy.
Cardiovasc Pharm Open Access. 4:1542015.PubMed/NCBI
|
|
19
|
Xu H, Zhou Y, Coughlan KA, Ding Y, Wang S,
Wu Y, Song P and Zou MH: AMPKα1 deficiency promotes cellular
proliferation and DNA damage via p21 reduction in mouse embryonic
fibroblasts. Biochim Biophys Acta. 1853:65–73. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Su KH, Yu YB, Hou HH, Zhao JF, Kou YR,
Cheng LC, Shyue SK and Lee TS: AMP-activated protein kinase
mediates erythropoietin-induced activation of endothelial nitric
oxide synthase. J Cell Physiol. 227:3053–3062. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Monteverde T, Muthalagu N, Port J and
Murphy DJ: Evidence of cancer-promoting roles for AMPK and related
kinases. FEBS J. 282:4658–4671. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang Y, Wang B, Guerram M, Sun L, Shi W,
Tian C, Zhu X, Jiang Z and Zhang L: Deoxypodophyllotoxin suppresses
tumor vasculature in HUVECs by promoting cytoskeleton remodeling
through LKB1-AMPK dependent Rho A activation. Oncotarget.
6:29497–29512. 2015.PubMed/NCBI
|
|
23
|
Altomare DA and Testa JR: Perturbations of
the AKT signaling pathway in human cancer. Oncogene. 24:7455–7464.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Brugarolas J and Kaelin WG Jr:
Dysregulation of HIF and VEGF is a unifying feature of the familial
hamartoma syndromes. Cancer Cell. 6:7–10. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Amin MB, Edge SB, Greene FL, Byrd DR,
Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR,
Sullivan DC, et al: AJCC Cancer Staging Manual. (8th). 2018.
|
|
26
|
Dong SM, Kim KM, Kim SY, Shin MS, Na EY,
Lee SH, Park WS, Yoo NJ, Jang JJ, Yoon CY, et al: Frequent somatic
mutations in serine/threonine kinase 11/Peutz-Jeghers syndrome gene
in left-sided colon cancer. Cancer Res. 58:3787–3790.
1998.PubMed/NCBI
|
|
27
|
Li W, Wang QL, Liu X, Dong SH, Li HX, Li
CY, Guo LS, Gao JM, Berger NA, Li L, et al: Combined use of vitamin
D3 and metformin exhibits synergistic chemopreventive effects on
colorectal neoplasia in rats and mice. Cancer Prev Res. 8:139–148.
2015. View Article : Google Scholar
|
|
28
|
Zaafar DK, Zaitone SA and Moustafa YM:
Role of metformin in suppressing 1,2-dimethylhydrazine-induced
colon cancer in diabetic and non-diabetic mice: Effect on tumor
angiogenesis and cell proliferation. PLoS One. 9:e1005622014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wu CY, Wang CJ, Tseng CC, Chen HP, Wu MS,
Lin JT, Inoue H and Chen GH: Helicobacter pylori promote gastric
cancer cells invasion through NF-kappaB and COX-2-mediated pathway.
World J Gastroenterol. 11:3197–3203. 2005. View Article : Google Scholar : PubMed/NCBI
|
